Investing Profile

Jerel Davis

VCInvestor
Managing Director at Versant Ventures
Photo of Jerel Davis, Managing Partner at Versant Ventures
Stanford University Network
513 CONNECTIONS
cb
Versant Ventures Managing Partner
$100K - $5.0M
$1.5M
19
$102.2M
CompanyStageDateRound SizeTotal Raised
Borealis Biosciences
Series AAug 2024$150M
$150M
Firefly Bio
Series AFeb 2024$94M
$94M
Co-investors: Todd Foley (MPM Capital)
Tentarix Biotherapeutics
Series BSep 2023$35M
Series AOct 2021$50M
$85M
Co-investors: Paul Grayson (Versant Ventures), Marcos Milla (Samsara BioCapital), Allyson Tighe (Amplitude VC)
Santa Ana Bio
Series AFeb 2023$43M
$170M
Co-investors: Vineeta Agarwala (Andreessen Horowitz), Brendan Bulik-Sullivan (GV (Google Ventures)), Christine Borowski (Access Biotechnology), Peter Emtage (Versant Ventures), Shinichiro Fuse
Ventus Therapeutics
Series CFeb 2022$140M
Series BApr 2021$100M
Series AMay 2020$60M
$300M
Co-investors: Brendan Bulik-Sullivan (GV (Google Ventures))
Turnstone Biologics
Series DJul 2021$80M
Series BNov 2016$41M
Series AOct 2015$11M
$130M
Co-investors: Rishi Gupta (OrbiMed)
RayzeBio
Series CJun 2021$110M
Series BDec 2020$110M
Series AOct 2020$45M
$420M
Co-investors: Aaron Royston (venBio), bong koh (KohFounders), Maha Katabi (Sofinnova Investments), Bong Koh (Venrock)
Graphite Bio
Series BMar 2021$150M
Series ASep 2020$45M
$200M
Co-investors: Jake Simson (RA Capital), Carlo Rizzuto (Versant Ventures), Abe Bassan (Samsara BioCapital)
Managing Director Versant Ventures2011 - Present
Stanford University PhD
Pepperdine University BS